J Huebner

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Coagulase-negative staphylococci: role as pathogens
    J Huebner
    Dept of Infectious Diseases, Children s Hospital, Boston, Massachusetts, USA
    Annu Rev Med 50:223-36. 1999
  2. ncbi Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci
    J Huebner
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Infect Immun 68:4631-6. 2000
  3. ncbi Distribution of four capsular serotypes of Enterococcus faecalis among clinical isolates from different geographical origins and infection sites
    M Hufnagel
    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    Infection 34:22-5. 2006
  4. ncbi Control of multiply resistant cocci: do international comparisons help?
    S Harbarth
    Children s Hospital, and Harvard Medical School, Boston, USA
    Lancet Infect Dis 1:251-61. 2001
  5. ncbi Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium
    Y Wang
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115 5804, USA
    Carbohydr Res 316:155-60. 1999
  6. ncbi Analysis of the specific immune response against capsular polysaccharides of two patients with systemic enterococcal infections
    M Hufnagel
    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    Infection 33:373-6. 2005
  7. ncbi In vitro assessment of the host response against Enterococcus faecalis used in probiotic preparations
    A Kropec
    Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    Infection 33:377-9. 2005

Detail Information

Publications7

  1. ncbi Coagulase-negative staphylococci: role as pathogens
    J Huebner
    Dept of Infectious Diseases, Children s Hospital, Boston, Massachusetts, USA
    Annu Rev Med 50:223-36. 1999
    ..Intravenous treatment of systemic infections is usually required because coagulase-negative staphylococci have become increasingly resistant to multiple antibiotics...
  2. ncbi Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci
    J Huebner
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Infect Immun 68:4631-6. 2000
    ..These data indicate that CP antigens from enterococci are potential targets of protective antibodies and that these antibodies may be useful for prophylaxis and treatment of enterococcal infections...
  3. ncbi Distribution of four capsular serotypes of Enterococcus faecalis among clinical isolates from different geographical origins and infection sites
    M Hufnagel
    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    Infection 34:22-5. 2006
    ..CONCLUSION: Half of the strain collection could be typed with four serotype-specific sera. No serotype from a given country or infection site clearly predominated...
  4. ncbi Control of multiply resistant cocci: do international comparisons help?
    S Harbarth
    Children s Hospital, and Harvard Medical School, Boston, USA
    Lancet Infect Dis 1:251-61. 2001
    ..Finally, we suggest that a macro-level perspective on antibiotic resistance can broaden the understanding of this worldwide calamity, and help prevent further dissemination of multiply resistant microorganisms...
  5. ncbi Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium
    Y Wang
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115 5804, USA
    Carbohydr Res 316:155-60. 1999
    ..It was composed of glucose, glycerol, and phosphate as determined by chemical and GC-MS analysis. The repeating-unit structure was elucidated by a series of 1H, 13C, and 31P NMR spectroscopy to be the following: [formula: see text]..
  6. ncbi Analysis of the specific immune response against capsular polysaccharides of two patients with systemic enterococcal infections
    M Hufnagel
    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    Infection 33:373-6. 2005
    ..We conclude, therefore, that systemic infection with enterococci does not lead to higher antibody concentrations or better opsonic killing against the causative capsular serotype...
  7. ncbi In vitro assessment of the host response against Enterococcus faecalis used in probiotic preparations
    A Kropec
    Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
    Infection 33:377-9. 2005
    ..This information may be helpful in assessing the safety of a given bacterial isolate used and could detect likely enterococcal candidates for probiotic preparations...